National Lung Cancer Audit


Research

Requests for secondary use of data

The NLCA team is committed to sharing the NLCA data and ensuring the greatest possible use comes from the hard work of collection. Applications for accessing data are now being received and processed by the Office for Data Release (ODR) at the National Cancer Registration and Analysis Service.

If you have any further questions please email the ODR at odr@phe.gov.uk or the NLCA team at NLCA@rcplondon.ac.uk.

NLCA Academic Publications

  • Khakwani A, Jack R H, Vernon S, Dickinson R, Wood N, Harden S, Beckett P, Woolhouse I, Hubbard R B. Apples and Pears? A comparison of two sources of national lung cancer audit data in England. ERJ Open Research 2017; 3: 00003‐2017. doi: 10.1183/23120541.00003‐2017
  • Hobbins S, West D, Peake M, et al. Patient characteristics, treatment and survival in pulmonary carcinoid tumours: an analysis from the UK National Lung Cancer Audit. BMJ Open 2016; 6:e012530. doi:10.1136/bmjopen‐2016‐ 012530
  • Peake M, Beckett P, Woolhouse I. 10 years of National Lung Cancer Audit in the UK. J Thoracic Onc, 2015; 10(9): Suppl 2: S382
  • Cusworth K, O’Dowd E, Hubbard R, et al. Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit. Thorax Published OnlineFirst: 2015. doi:10.1136/thoraxjnl‐ 2015‐207166
  • Rich AL, Khakwani A, Free CM, et al. Non‐small cell lung cancer in young adults: presentation and survival in the English National Lung Cancer Audit. QJM Published Online First: 2015. doi:10.1093/qjmed/hcv052
  • Beckett P, Edwards J, Fennell D, et al. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer Published Online First: 2015. doi:10.1016/j.lungcan.2015.03.005
  • Russell GK, Jimenez S, Martin L, et al. A multicentre randomised controlled trial of reciprocal lung cancer peer review and supported quality improvement: results from the improving lung cancer outcomes project. Br J Cancer 2014;110:1936–42. doi:10.1038/bjc.2014.146
  • Powell HA, Tata LJ, Baldwin DR, et al. Treatment decisions and survival for people with small‐cell lung cancer. Br J Cancer 2014;110:908–15. doi:10.1038/bjc.2013.812
  • Khakwani A, Rich AL, Tata LJ, et al. Small‐cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit. PLoS One 2014;9:e89426. doi:10.1371/journal.pone.0089426
  • Khakwani A, Rich AL, Powell HA, et al. The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery. Thorax Published Online First: 2 September 2014. doi:10.1136/thoraxjnl‐2014‐ 205841
  • Beckett P, Tata LJ, Hubbard RB. Risk factors and survival outcome for non‐elective referral in non‐small cell lung cancer patients ‐ Analysis based on the National Lung Cancer Audit. Lung Cancer 2014;83:396–400. doi:10.1016/j.lungcan.2013.10.010
  • Woolhouse I, Stanley R, Slade M, et al. P2 Trends in lung cancer diagnostics, does the timing of tests matter? Results from the National Lung Cancer Audit 2009‐2011. Thorax 2013;68:A75–A75. doi:10.1136/thoraxjnl‐ 2013‐204457.152
  • Woolhouse I, Stanley R, Callister M, et al. S107 Treatment and outcomes for locally advanced (stage IIIA) lung cancer; 4 year experience from the National Lung Cancer Audit. Thorax 2013;68:A56–7. doi:10.1136/thoraxjnl‐2013‐204457.114
  • Powell HA, Tata LJ, Baldwin DR, et al. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Thorax 2013;68:826–34. doi:10.1136/thoraxjnl‐2012‐203123
  • Lau KKW, Rathinam S, Waller DA, et al. The effects of increased provision of thoracic surgical specialists on the variation in lung cancer resection rate in England. J Thorac Oncol 2013;8:68–72. doi:10.1097/JTO.0b013e3182762315
  • Khakwani A, Rich AL, Tata LJ, et al. The pathological confirmation rate of lung cancer in England using the NLCA database. Lung Cancer 2013;79:125–31. doi:10.1016/j.lungcan.2012.11.005
  • Khakwani A, Rich AL, Powell HA, et al. Lung cancer survival in England: trends in non‐small‐cell lung cancer survival over the duration of the National Lung Cancer Audit. Br J Cancer Published Online First: 19 September 2013. doi:10.1038/bjc.2013.572
  • Beckett P, Hubbard R, Stanley R, et al. Higher resection rates in non‐small cell lung cancer are associated with better survival. In: British Thoracic Oncology Group Conference. 2013. 71. doi:10.1016/S0169‐ 5002(13)70207‐1
  • Beckett P, Woolhouse I, Stanley R, et al. S106 ‘Reasons to be cheerful’‐data from year 8 of the national lung cancer audit. Thorax 2013;68:A56–A56. doi:10.1136/thoraxjnl‐2013‐204457.113
  • Beckett P, Woolhouse I, Stanley R, et al. P1 An analysis of 8,503 cases of mesothelioma from the National Lung Cancer Audit. Thorax 2013;68:A75–A75. doi:10.1136/thoraxjnl‐2013‐204457.151
  • Riaz SP, Linklater KM, Horton M, et al. Lung cancer data in the National Cancer Data Repository , Hospital Episode Statistics and National Lung Cancer Audit datasets A comparison of case ascertainment and recording. 2012.
  • Musial N, Stanley R, Beckett P, et al. 120 Carcinoid tumour characteristics, treatment and outcome: results from the National Lung Cancer Audit 2005–2010. Lung Cancer. 2012;75:S39–40. doi:10.1016/S0169‐ 5002(12)70121‐6
  • Beckett P, Callister M, Tata LJ, et al. Clinical management of older people with non‐small cell lung cancer in England. Thorax 2012;67:836–9. doi:10.1136/thoraxjnl‐2011‐200994
  • Beckett P, Woolhouse I, Stanley R, et al. Exploring variations in lung cancer care across the UK‐‐the ‘story so far’ for the National Lung Cancer Audit. Clin Med 2012;12:14–18.http://www.ncbi.nlm.nih.gov/pubmed/22372213 (accessed 8 Oct2013).
  • Beckett P, Woolhouse I. Inequalities in outcomes for non‐small cell lung cancer: the role of the MDT. Thorax. 2012;67:926–7. doi:10.1136/thoraxjnl‐2012‐201582
  • Beckett P, Peake M, Woolhouse I, et al. 87 Workload of lung cancer MDTs is not associated with outcome. Lung Cancer. 2012;75:S29. doi:10.1016/S0169‐5002(12)70088‐0
  • Beckett P, Peake M, Woolhouse I, et al. S90 The National Lung Cancer Audit ‐ No Evidence of a ‘Seven‐Year Itch’. Thorax 2012;67:A43–4. doi:10.1136/thoraxjnl‐2012‐202678.096
  • Aveling E‐L, Martin G, Jimenez Garcia S, et al. Reciprocal peer review for quality improvement: an ethnographic case study of the Improving Lung Cancer Outcomes Project. BMJ Qual Saf 2012;:1–9. doi:10.1136/bmjqs‐2012‐000944
  • Rich AL, Tata LJ, Free CM, et al. Inequalities in outcomes for non‐small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 2011;66:1078–84. doi:10.1136/thx.2011.158972
  • Rich AL, Tata LJ, Free CM, et al. How do patient and hospital features influence outcomes in small‐cell lung cancer in England? Br J Cancer 2011;105:746–52. doi:10.1038/bjc.2011.310
  • Beckett P, Woolhouse I, Stanley R, et al. P152 The National Lung Cancer Audit: year 6 completeness and outcomes. Thorax. 2011;66:A129–A129. doi:10.1136/thoraxjnl‐2011‐201054c.152
  • Beckett P, Woolhouse I, Stanley R, et al. S90 Nurse specialist input is independently associated with anticancer treatment in lung cancer. Thorax. 2011;66:A42–3. doi:10.1136/thoraxjnl‐2011‐201054b.90
  • Beckett P, Stanley R, Woolhouse I, et al. 90 The National Lung Cancer Audit ‐ year 5 completeness and outcomes and case‐mix adjustment. Lung Cancer. 2011;71:S31. doi:10.1016/S0169‐5002(11)70090‐3
  • Woolhouse I, Beckett P, Stanley RA, et al. Influence of case‐mix adjustment on outcomes in the National Lung Cancer Audit. Lung Cancer. 2010;67:S22. doi:10.1016/S0169‐5002(10)70065‐9
  • Rich AL, Tata LJ, Stanley RA, et al. Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA). Lung cancer Published Online First: August 2010. doi:10.1016/j.lungcan.2010.07.002
  • Beckett P, Woolhouse I, Stanley RA, et al. The National Lung Cancer Audit Headline results in year 4. Lung Cancer. 2010;67:S21–2. doi:10.1016/S0169‐5002(10)70063‐5
  • Beckett P, Woolhouse I, Stanley R, et al. P210 The national lung cancer audit‐‐year 5 completeness and outcomes. Thorax. 2010;65:A165–6. doi:10.1136/thx.2010.151068.11
  • Beckett P, Stanley RA, Woolhouse I, et al. Small cell lung cancer in the National Lung Cancer Audit. Lung Cancer. 2010;67:S10. doi:10.1016/S0169‐5002(10)70029‐5
  • Rich AL, Free CM, Beckett P, et al. The National Lung Cancer Audit Database (LUCADA); essential analysis of data quality. Lung Cancer 2009;63:S14–5.
  • Beckett P, Stanley R, Peake MD. Use of chemotherapy in advanced NSCLC – results from the National Lung Cancer Audit. Lung Cancer. 2009;63:S3. doi:10.1016/S0169‐5002(09)70009‐1
  • Beckett P, Stanley R, Peake MD. The National Lung Cancer Audit in the United Kingdom: key messages after 2 years of data collection. Lung Cancer. 2008;60:S15. doi:10.1016/S0169‐5002(08)70047‐3

Copyright © 2017 National Lung Cancer Audit